CM
Claire Mazumdar (Chief Executive Officer) filed 7 Form 4 reports in the trailing twelve months (0 purchases, 7 sales), most often in Bicara Therapeutics Inc. (BCAX). The largest single filing was $776K of BCAX (41,163 sh × $18.86, as filed), executed Nov 24 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
7
0 buys · 7 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$2.1M
shares × price, as filed
Last traded
Aug 10
Filed Aug 12
Median ADV $19.3M across their filed names
Open performance→Volume by month
Buys $0
Sells $3.8M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
7 filings
Sector per market data · by filing · past 12 months
Most traded names
BCAXRecent filings
BCAXSALE
Bicara Therapeutics Inc.
View filing →
$280K10,000 sh × $27.98
Exec Aug 10
Filed Aug 12 · 4:19 PM ET BCAXSALE Bicara Therapeutics Inc. View filing → $283K
9,972 sh × $28.42
Exec Jul 10
Filed Jul 14 · 4:22 PM ET BCAXSALE Bicara Therapeutics Inc. View filing → $240K
12,022 sh × $19.96
Exec May 18
Filed May 20 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. View filing → $354K
15,000 sh × $23.61
Exec Apr 20
Filed Apr 20 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. View filing → $252K
13,404 sh across 2 lots
Exec Mar 18
Filed Mar 20 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. View filing → $705K
36,766 sh × $19.17
Exec Mar 9
Filed Mar 11 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. View filing → $776K
41,163 sh × $18.86
Exec Nov 24 2025
Filed Nov 25 2025 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. View filing → $454K
24,103 sh × $18.83
Exec Oct 16 2025
Filed Oct 20 2025 · 5:30 PM ET More filings →